Drug-induced vanishing bile duct syndrome: response to ursodiol.
O'Brien
C B
CB
Department of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Shields
D S
DS
Saul
S H
SH
Reddy
K R
KR
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001649:Bile Duct Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002779:Cholestasis / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008875:Middle Aged; D011346:Prochlorperazine / Q000009:adverse effects*; D013577:Syndrome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid; D011346:Prochlorperazine